Interplay between Zika Virus and Peroxisomes during Infection.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
15 07 2019
Historique:
received: 30 05 2019
revised: 10 07 2019
accepted: 12 07 2019
entrez: 18 7 2019
pubmed: 18 7 2019
medline: 11 2 2020
Statut: epublish

Résumé

Zika virus (ZIKV) has emerged as an important human pathogen that can cause congenital defects in the fetus and neurological conditions in adults. The interferon (IFN) system has proven crucial in restricting ZIKV replication and pathogenesis. The canonical IFN response is triggered by the detection of viral RNA through RIG-I like receptors followed by activation of the adaptor protein MAVS on mitochondrial membranes. Recent studies have shown that a second organelle, peroxisomes, also function as a signaling platforms for the IFN response. Here, we investigated how ZIKV infection affects peroxisome biogenesis and antiviral signaling. We show that ZIKV infection depletes peroxisomes in human fetal astrocytes, a brain cell type that can support persistent infection. The peroxisome biogenesis factor PEX11B was shown to inhibit ZIKV replication, likely by increasing peroxisome numbers and enhancing downstream IFN-dependent antiviral signaling. Given that peroxisomes play critical roles in brain development and nerve function, our studies provide important insights into the roles of peroxisomes in regulating ZIKV infection and potentially neuropathogenesis.

Identifiants

pubmed: 31311201
pii: cells8070725
doi: 10.3390/cells8070725
pmc: PMC6678468
pii:
doi:

Substances chimiques

Membrane Proteins 0
PEX11B protein, human 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : PJT-148699
Pays : Canada
Organisme : CIHR
ID : ZV1-149782
Pays : Canada

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

J Immunol Res. 2018 Apr 30;2018:9480497
pubmed: 29854853
Nat Immunol. 2014 Aug;15(8):717-26
pubmed: 24952503
Curr Opin Microbiol. 2016 Aug;32:113-119
pubmed: 27288760
Cell Host Microbe. 2016 May 11;19(5):720-30
pubmed: 27066744
Virology. 2015 May;479-480:110-21
pubmed: 25749629
Cell. 2010 May 14;141(4):668-81
pubmed: 20451243
Mol Cell Proteomics. 2018 Nov;17(11):2242-2255
pubmed: 30037810
J Virol. 2013 Jan;87(2):872-81
pubmed: 23115297
J Virol. 2018 Jan 30;92(4):
pubmed: 29187542
Cell. 2016 Aug 25;166(5):1247-1256.e4
pubmed: 27565347
EMBO Rep. 2016 Dec;17(12):1766-1775
pubmed: 27797853
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14408-14413
pubmed: 27911847
Cell Host Microbe. 2018 Oct 10;24(4):526-541.e7
pubmed: 30269970
Biogerontology. 2018 Oct;19(5):303-324
pubmed: 29968207
PLoS Negl Trop Dis. 2013 Apr 18;7(4):e2178
pubmed: 23638199
J Cell Mol Med. 2016 Apr;20(4):750-7
pubmed: 26865163
J Virol. 2011 Nov;85(22):11557-66
pubmed: 21880757
Nat Commun. 2018 Jan 29;9(1):414
pubmed: 29379028
Cell Host Microbe. 2016 Jun 8;19(6):882-90
pubmed: 27212660
PLoS Pathog. 2017 Jun 8;13(6):e1006360
pubmed: 28594894
EMBO J. 2011 Jan 5;30(1):5-16
pubmed: 21113128
J Infect Dis. 2019 Sep 13;220(8):1377-1387
pubmed: 30799482
Cell Microbiol. 2014 Jun;16(6):834-48
pubmed: 24245804
Nat Genet. 2007 Aug;39(8):969-76
pubmed: 17643102
Cell Discov. 2018 Apr 24;4:19
pubmed: 29707233
Rev Med Virol. 2012 Jul;22(4):257-66
pubmed: 22359246
Hepatology. 2005 Sep;42(3):702-10
pubmed: 16108059
Nature. 2018 Sep;561(7722):253-257
pubmed: 30177828
Lancet. 2016 May 21;387(10033):2070-2072
pubmed: 26993880
Glia. 2010 Oct;58(13):1532-43
pubmed: 20578053
PLoS Pathog. 2015 Nov 20;11(11):e1005264
pubmed: 26588843
Am J Trop Med Hyg. 2014 Dec;91(6):1235-1242
pubmed: 25294616
Curr Opin Virol. 2011 Dec;1(6):476-86
pubmed: 22323926
J Virol. 2017 Jul 27;91(16):
pubmed: 28592527
PLoS Negl Trop Dis. 2016 Apr 19;10(4):e0004682
pubmed: 27093158
Lancet. 2008 Feb 9;371(9611):500-9
pubmed: 18262042
Nat Rev Immunol. 2005 May;5(5):375-86
pubmed: 15864272
mSphere. 2016 Sep 28;1(5):
pubmed: 27704051
Immunity. 2007 Sep;27(3):370-83
pubmed: 17892846
N Engl J Med. 2016 Mar 10;374(10):984-5
pubmed: 26862812
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Arch Virol. 2007;152(4):687-96
pubmed: 17195954
mBio. 2015 May 12;6(3):e00553-15
pubmed: 25968648
J Virol. 1968 Oct;2(10):955-61
pubmed: 4302013
Hepatology. 2011 Nov;54(5):1506-17
pubmed: 22045669
Histochem Cell Biol. 2018 Nov;150(5):443-471
pubmed: 30219925
J Virol. 2015 Dec;89(24):12349-61
pubmed: 26423946
J Biol Chem. 1998 Nov 6;273(45):29607-14
pubmed: 9792670
J Virol. 2009 Jun;83(11):5408-18
pubmed: 19279106
Viruses. 2018 Nov 17;10(11):
pubmed: 30453621
Sci Rep. 2017 Jun 30;7(1):4475
pubmed: 28667332
DNA Cell Biol. 2018 May;37(5):417-421
pubmed: 29443540
J Cell Biol. 1989 May;108(5):1657-64
pubmed: 2654139

Auteurs

Cheung Pang Wong (CP)

Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB T6G 2E1, Canada.

Zaikun Xu (Z)

Department of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.

Shangmei Hou (S)

Department of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.

Daniel Limonta (D)

Department of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.

Anil Kumar (A)

Department of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.

Christopher Power (C)

Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB T6G 2E1, Canada.
Department of Medicine, University of Alberta, Edmonton, AB T6G 2E1, Canada.
Women & Children's Health Research Institute, University of Alberta, Edmonton, AB T6G 1C9, Canada.
Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB T6G 2E1, Canada.

Tom C Hobman (TC)

Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB T6G 2E1, Canada. tom.hobman@ualberta.ca.
Department of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada. tom.hobman@ualberta.ca.
Women & Children's Health Research Institute, University of Alberta, Edmonton, AB T6G 1C9, Canada. tom.hobman@ualberta.ca.
Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB T6G 2E1, Canada. tom.hobman@ualberta.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH